Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2013, Article ID 548064, 7 pages
http://dx.doi.org/10.1155/2013/548064
Research Article

Posttranslational Protein Modification in the Salivary Glands of Sjögren’s Syndrome Patients

Department of Immunology, School of Biological Sciences, Universidad Autónoma de Zacatecas, Chepinque 306, Colonia Lomas de la Soledad, 98040 Zacatecas, ZAC, Mexico

Received 5 November 2012; Accepted 2 January 2013

Academic Editor: Ricard Cervera

Copyright © 2013 Rafael Herrera-Esparza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. M. Moutsopoulos, “Sjogren's syndrome: autoimmune epithelitis,” Clinical Immunology and Immunopathology, vol. 72, no. 2, pp. 162–165, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Wada, “Über citrullin, eine neue aminosäure im presssaft der wassermelone, citrullus vulgaris schrad,” Biochemische Zeitschrift, vol. 224, pp. 420–429, 1930. View at Google Scholar
  3. H. A. Krebs and K. Henseleit, “Studies on urea formation in the animal organism,” Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, vol. 210, pp. 33–66, 1932. View at Google Scholar
  4. E. Curis, I. Nicolis, C. Moinard et al., “Almost all about citrulline in mammals,” Amino Acids, vol. 29, no. 3, pp. 177–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Bollain-Y-Goytia, L. Mendoza-Salazar, M. D. L. Romo-Flores et al., “The presence of citrulline in salivary glands is evidence that nitric oxide is mediator of inflammation in Sjögren acinar epithelia,” International Journal of Rheumatic Diseases, vol. 11, no. 3, pp. 263–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Badillo-Almaraz, E. Avalos-Díaz, R. Villalobos-Hurtado, and R. Herrera-Esparza, “FasL and Bax genes are differentially expressed in acinar epithelium and inflammatory cells of primary Sjögren glands,” Minerva Medica, vol. 94, no. 5, pp. 341–345, 2003. View at Google Scholar · View at Scopus
  7. J. J. B. C. van Beers, R. Raijmakers, L. E. Alexander et al., “Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance,” Arthritis Research & Therapy, vol. 12, no. 6, article R219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. van Beers, A. Willemze, J. Stammen-Vogelzangs, J. W. Drijfhout, R. E. Toes, and G. J. Pruijn, “Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles,” Arthritis Research & Therapy, vol. 14, no. 1, article R35, pp. 1–16, 2012. View at Publisher · View at Google Scholar
  9. J. E. Gottenberg, S. Mignot, P. Nicaise-Rolland et al., “Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 64, no. 1, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Atzeni, P. Sarzi-Puttini, N. Lama et al., “Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis,” Arthritis Research & Therapy, vol. 10, no. 3, article R51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. K. Acharya, E. P. Nagele, M. Han et al., “Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease,” Journal of Autoimmunity, vol. 38, no. 4, pp. 369–380, 2012. View at Publisher · View at Google Scholar
  12. C. Vitali, S. Bombardieri, R. Jonsson et al., “European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Google Scholar
  13. D. M. Chisholm and D. K. Mason, “Labial salivary gland biopsy in Sjögren’s syndrome,” Journal of Clinical Pathology, vol. 21, no. 5, pp. 656–660, 1968. View at Google Scholar
  14. N. Bizzaro, E. Tonutti, R. Tozzoli, and D. Villalta, “Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins,” Clinical Chemistry, vol. 53, no. 8, pp. 1527–1533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Herrera Esparza, T. Swaak, L. Aarden, and R. Smeenk, “Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal,” Journal of Rheumatology, vol. 12, no. 6, pp. 1109–1117, 1985. View at Google Scholar · View at Scopus
  16. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  17. S. Avrameas and T. Ternynck, “Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration,” Immunochemistry, vol. 8, no. 12, pp. 1175–1179, 1971. View at Google Scholar · View at Scopus
  18. S. Horibata, S. A. Coonrod, and B. D. Cherrinton, “Role for the peptydilarginine deiminase in disease and female reproduction,” The Journal of Reproduction and Development, vol. 58, no. 3, pp. 274–282, 2012. View at Google Scholar
  19. H. Terakawa, H. Takahara, and K. Sugawara, “Three types of mouse peptidylarginine deiminase: characterization and tissue distribution,” Journal of Biochemistry, vol. 110, no. 4, pp. 661–666, 1991. View at Google Scholar · View at Scopus
  20. E. R. Vossenaar, T. R. D. Radstake, A. van der Heijden et al., “Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages,” Annals of the Rheumatic Diseases, vol. 63, no. 4, pp. 373–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Hjelmervik, R. Jonsson, and A. Bolstad, “The minor salivary gland proteome in Sjögren's syndrome,” Oral Diseases, vol. 15, no. 5, pp. 342–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Dang, A. L. Lin, B. Zhang, H. M. Zhang, M. S. Katz, and C. K. Yeh, “Role for Notch signaling in salivary acinar cell growth and differentiation,” Developmental Dynamics, vol. 238, no. 3, pp. 724–731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. P. Harvey, T. R. Fitzsimmons, A. A. Dhamarpatni, C. Marchant, D. R. Haynes, and P. M. Bartold, “Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva,” Journal of Periodontal Research, 2012. View at Publisher · View at Google Scholar
  24. R. L. Nienhuis and E. Mandema, “A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor,” Annals of the Rheumatic Diseases, vol. 23, pp. 302–305, 1964. View at Google Scholar · View at Scopus
  25. R. M. A. Hoet, T. A. M. Boerbooms, M. Arends, D. J. Ruiter, and W. J. van Venrooij, “Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin,” Annals of the Rheumatic Diseases, vol. 50, no. 9, pp. 611–618, 1991. View at Google Scholar · View at Scopus
  26. G. A. Schellekens, B. A. W. de Jong, F. H. J. van Den Hoogen, L. B. A. van De Putte, and W. J. van Venrooij, “Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies,” Journal of Clinical Investigation, vol. 101, no. 1, pp. 273–281, 1998. View at Google Scholar · View at Scopus
  27. N. Després, G. Talbot, B. Plouffe, G. Boire, and H. A. Ménard, “Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1891–1896, 1995. View at Google Scholar · View at Scopus
  28. E. R. Vossenaar, N. Després, E. Lapointe et al., “Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin,” Arthritis Research & Therapy, vol. 6, no. 2, pp. R142–R150, 2004. View at Google Scholar · View at Scopus
  29. H. A. Doyle and M. J. Mamula, “Post-translational protein modifications in antigen recognition and autoimmunity,” Trends in Immunology, vol. 22, no. 8, pp. 443–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. L. M. Sollid, “Coeliac disease: dissecting a complex inflammatory disorder,” Nature Reviews Immunology, vol. 2, no. 9, pp. 647–655, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. T. Bedford and S. Richard, “Arginine methylation: an emerging regulator of protein function,” Molecular Cell, vol. 18, no. 3, pp. 263–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. E. R. Vossenaar, T. J. M. Smeets, M. C. Kraan, J. M. Raats, W. J. van Venrooij, and P. P. Tak, “The presence of citrullinated proteins is not specific for rheumatoid synovial tissue,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3485–3494, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. A. Stea, J. G. Routsias, M. Samiotaki et al., “Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets,” Clinical and Experimental Immunology, vol. 147, no. 1, pp. 81–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. G. Routsias and A. G. Tzioufas, “Autoimmune response and target autoantigens in Sjogren's syndrome,” European Journal of Clinical Investigation, vol. 40, no. 11, pp. 1026–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus